GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Archived. This submission is more than a year old. Votes and new comments are closed, and some of the advice in it may have been superseded — check the community wiki for the current version.
2.7k
c/compounding·posted 1 year ago by u/lina_ndiaye

[Discussion] can we stop arguing about telehealth until somebody posts a number

Discussion Receipts ×4 Slow Clap ×2 Cold Box ×3

Trying to settle this properly because the thread from last year went in circles.

The claim: state board matters. The counter-claim: it is measurement error. Both sides have been asserting it confidently for about 17 months without either producing anything.

What would actually settle it is 17 people measuring the same thing the same way. I have started; my numbers are below. They lean one way but not strongly enough for me to declare victory.

If you have data, post the data. If you have an opinion, flair it as an opinion.

3,221 up / 522 down86% upvoted46 commentsid 1mv1wa1 Nov 2024

46 comments

23 in this archive, depth 5

best — the order this archive was captured in

u/burned_once_twice-33 points·1 year ago

the shortage list is temporary, it ends and compounding becomes illegal again

replysharereportpermalink
u/lina_ndiayeOP1 point·1 year ago

Moved states and the compounding landscape changed completely. Different rules, different pharmacies, different costs.

replysharereportpermalink
u/runa_grimaldi1 point·1 year ago

Moved states and the compounding landscape changed completely.

Adding to this: 503B is doing more work than the comment implies.

replysharereportpermalink
u/lipid_panel_larrybloodwork1 point·1 year ago

telehealth costs 503A plus compounding markup, total varies

replysharereportpermalink
u/blunt_coldbox_notes1 point·1 year ago

the 503A/503B distinction is load-bearing, do not blur it

replysharereportpermalink
[removed]1 point·1 year ago

[removed by moderator]

replysharereportpermalink
u/emil_okwuosa321 points·1 year ago

API transparency is the question that separates good compounders from sketchy ones

replysharereportpermalink
u/yannick_barros137 points·1 year ago

API transparency is the question that separates good compounders from sketchy ones

Yes, exactly this, and it is the bit that took me 17 weeks to accept.

replysharereportpermalink
u/ignacio_vanhecke81 points·1 year ago

state board rules differ, say which state

replysharereportpermalink
u/receptor_bias_rick51 points·1 year ago

regulatory claims need a citation to the actual rule, not interpretation

replysharereportpermalink
u/rania_diallo16 points·1 year ago·edited

regulatory claims need a citation to the actual rule, not interpretation

Disagree on that part. 96.2% and 96.8% on the same vial is normal.

replysharereportpermalink
u/slow_logbook49 points·1 year ago

Strongly agree. API source transparency matters.

replysharereportpermalink
u/emeka_chowdhury313 points·1 year ago

state board rules differ, say which state

replysharereportpermalink
u/escrow_evangelist96 points·1 year ago·edited

state board rules differ, say which state

Counter-anecdote: opposite result, same dose. Which mostly tells us the variance is huge.

replysharereportpermalink
u/teodor_duarte75 points·1 year ago·edited

no pharmacy referral codes, naming is fine, recruiting is not

replysharereportpermalink
u/lina_ndiayeOP29 points·1 year ago

no pharmacy referral codes, naming is fine, recruiting is not

Disagree on that part. 99.0% and 98.9% on the same vial is normal.

replysharereportpermalink
u/quiet_moderatormod85 points·1 year ago

Respectfully this is a sample of one presented as a finding.

replysharereportpermalink
u/formulary_fighterMOD206 points·1 year ago

Tracking number removed. It identifies both ends of a shipment.

replysharereportpermalink
u/cold_chromatogram31102 points·1 year ago

Three years on this site and the questions have not changed at all. Which is depressing or reassuring depending on the day.

replysharereportpermalink
u/lipid_panel_larrybloodwork62 points·1 year ago

Strongly agree. API source transparency matters.

replysharereportpermalink
u/liver_enzyme_liz67 points·1 year ago

Strongly agree. API source transparency matters.

replysharereportpermalink
u/ffmi_watcher96 points·1 year ago

Not convinced. The evidence does not support that reading.

replysharereportpermalink
u/lina_ndiayeOP27 points·1 year ago

The 503A pharmacy I used lost their shortage list eligibility. Same day, compounding became illegal. Rules are real.

replysharereportpermalink
Permalinked branches
Deep branches get their own page so a single reply chain can be linked and read on its own.
About c/compounding

Compounded GLP-1s as a supply route: the 503A/503B distinction, the shortage-list mechanics that made compounding legal and then didn't, state board rules, telehealth prescriber models, and what a compounding pharmacy will and will not tell you about its API source.

53kmembers
95submissions
Oct 2023created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
c/compounding rules
  1. Regulatory claims need a citation to the actual rule, notice or docket.
  2. No pharmacy referral codes. Naming a pharmacy is fine; recruiting for it is not.
  3. API source questions are on-topic and pharmacies dodging them is newsworthy.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.